Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of SLE related to estrogen.
Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of SLE related to estrogen.
复制标题
DOI:
10.1155/2014/814598
复制
发表时间:
2014
影响因子:
4.1
通讯作者:
Hou Y
中科院分区:
文献类型:
--
作者:
Fan H;Dong G;Zhao G;Liu F;Yao G;Zhu Y;Hou Y
The aim of the present study was to investigate mechanism of the gender differences of B cells. The results showed that 358 differential gene expressions (DEGs) were displayed between healthy females and males. Compared with male, 226 and 132 genes were found to be up- and downregulated in the female. 116 genes displayed possible correlation with estrogen. Moreover, the upregulated DEGs (Cav1, CD200R1, TNFRSF17, and CXCR3) and downregulated DEGs (EIF1AY and DDX3Y) in healthy female may be involved in gender predominance of some immune diseases. Furthermore, signaling pathway analysis for estrogen-relevant DEGs showed that only 26 genes were downregulated in SLE female versus SLE male, of which expressions of 8 genes had significant difference between SLE females and SLE males but are having nonsignificant difference between healthy females and healthy males. Except for the 5 Y-chromosome-related genes or varients, only 3 DEGs (LTF, CAMP, and DEFA4) were selected and qRT-PCR confirmed that the expressions of LTF and CAMP decreased significantly in B cells from female SLE patients. These data indicated that the gender differences were existent in global gene expression of B cells and the difference may be related to estrogen.
登录
查看更多内容
影响因子:
6.5
作者:
Gilling, Christine E.;Mittal, Amit K.;Joshi, Shantaram S.
通讯作者:
Joshi, Shantaram S.
DOI:
10.1152/ajplung.00018.2012
发表时间:
2012-10-01
影响因子:
4.9
作者:
Aravamudan, Bharathi;VanOosten, Sarah K.;Pabelick, Christina M.
通讯作者:
Pabelick, Christina M.
影响因子:
3.7
作者:
Bund, D.;Buhmann, R.;Schmetzer, H. M.
通讯作者:
Schmetzer, H. M.
DOI:
10.1084/jem.20112398
发表时间:
2012-09-24
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Hara-Chikuma M;Chikuma S;Sugiyama Y;Kabashima K;Verkman AS;Inoue S;Miyachi Y
通讯作者:
Miyachi Y
影响因子:
3.6
作者:
Guo CJ;Yang XB;Wu YY;Yang LS;Mi S;Liu ZY;Jia KT;Huang YX;Weng SP;Yu XQ;He JG
通讯作者:
He JG